Communications leader helping the world understand biomedicine. Views here are my own.
Greater New York Metro
Joined June 2008
- Tweets6.2K
- Following3.2K
- Followers7.8K
- Likes3.5K
It’s not only time to develop our a.i. chops, it’s time to think hard about what will be left for humans to do in few years. Read more from @WSJ wsj.com/opinion/brace-yourse…
Ryan McBride retweeted
#NEWS: The FDA has approved our treatment for adults with moderately to severely active Crohn’s disease.
Learn more about what this means for the inflammatory bowel disease (IBD) community: bit.ly/4iM4p5D
#JNJImmunology
Thanks to @edyong209 for speaking last night in Philly at our patient advocacy event #HealtheVoices22, and how appropriate on the heels of his sabbatical announcement for Ed to talk up curiosity, kindness and empathy—qualities to take care of others and ourselves.
Our team is opening a state-of-the-art @JNJNews center today in the Bay Area—very exciting for our scientists, partners and other innovators. jnj.com/johnson-johnson-open…
Ryan McBride retweeted
J&J’s Najat Khan says we must adapt to do precision medicine clinical trials in the current system e.g. building an algorithm to understand tumor mutations from biopsies, because the vast majority of patients do not get their tumors sequenced. #FTpharma
Ryan McBride retweeted
Vaccines have an unparalleled impact in helping people live longer lives and can prevent both infectious diseases and major health crises, including COVID-19 and Ebola. #WorldImmunizationWeek #LongLifeForAll
Ryan McBride retweeted
At this year's @AACR Annual Meeting, we're sharing our latest advances in oncology as we aim to prevent, intercept and cure #cancer. #AACR22
bit.ly/3JlYLoC
Ryan McBride retweeted
The emerging role of mass spectrometry-based proteomics in drug discovery | Nature Reviews Drug Discovery nature.com/articles/s41573-0…
Ryan McBride retweeted
Our latest oncology company interview has just posted. This one explores the bridge between preclinical and phase 1 R&D as a pipeline gets replenished with promising new compounds: icar.us/374T7GK
Ryan McBride retweeted
Today’s encouraging news from Pfizer & BioNTech signals a possible breakthrough in combating COVID-19, which the world urgently needs. I commend the hard work of the researchers, scientists, clinicians & all those involved in bringing this forward quickly to address the pandemic
Ryan McBride retweeted
Estimated cost of recent epidemics/pandemics:
SARS (2003) - $40 billion
H5N1 (2006) - $40 billion
H1N1 (2009) - $45 billion
Ebola (2014) - $55 billion
COVID-19 (2020) - $8.8 TRILLION
Investing in public health preparedness is FAR cheaper than the economic impact of a pandemic.
Ryan McBride retweeted
As the pandemic heightened in China, Yan led a dedicated development team to respond to our current public health crisis. Their creativity & collaboration in the early phases of the pandemic helped us to prepare our continued support for patients enrolled in our #clinicaltrials.
Ryan McBride retweeted
Especially in low- and lower middle–income countries, managing #COVID19 and the related symptoms of the virus remains a pressing challenge. With this new portfolio, we’re building on our previous actions to help combat the pandemic around the world.
Early access to treatment for #COVID19 symptoms is critical. Novartis has announced a new initiative to help 79 low-income and lower-middle-income countries access affordable medicines to treat the major symptoms of the disease. #NovartisNews
Ryan McBride retweeted
The Remdesivir Pricing Letter that Gilead Sciences Should Have Written. By @PeterKolchinsky timmermanreport.com/2020/07/…
Ryan McBride retweeted
This pandemic has pushed the boundaries of how fast scientists can understand, track, and tackle a disease. Join me on June 25th for a conversation w/ @jaybradner & @davidrliu about how #COVID19 could change research. Register (free!) here: cenm.ag/covidscience1
Ryan McBride retweeted
Meet Florencia, a physician-scientist focused on infectious diseases. Florencia’s bringing her expertise to the fight against #COVID19, designing a large-scale trial to test the effectiveness of a potential treatment. #coronavirus
Ryan McBride retweeted
Happy to work together with a great team of @UCB_Chemistry @berkeleyMCB grad students, postdocs & @NovartisScience @jaybradner @ChemGenetics @Toste_Group @igisci to develop pan-coronavirus therapies! cen.acs.org/biological-chemi…
Ryan McBride retweeted
#COVID19 has created challenges & uncertainty for everyone, especially the cancer community. We want to share insights to help navigate this unprecedented time. Listen to Susanne Schaffert, PhD & breast cancer expert Fatima Cardoso from @Neuro_CF & @myESMO bddy.me/2VXBJxp
Ryan McBride retweeted
In the short-term, repurposing existing medicines to help treat #COVIDー19 is our best hope. We’re working to help generate the rigorous clinical testing and data needed to assess the safety and efficacy of some of the most promising options as quickly as possible. #COVID19
Novartis to sponsor large-scale clinical trial of hydroxychloroquine in hospitalized COVID-19 patients #COVID19 #coronavirus #NovartisNews